Ubiquilin 2 mutations in Italian patients with amyotrophic lateral sclerosis and frontotemporal dementia

Objectives Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease mainly involving cortical and spinal motor neurones. Molecular studies have recently identified different mutations in the ubiquilin-2 (UBQLN2) gene as causative of a familial form of X-linked ALS, 90% penetrant in women. The aim of our study was to analyse the UBQLN2 gene in a large cohort of patients with familial (FALS) and sporadic (SALS) amyotrophic lateral sclerosis, with or without frontotemporal dementia (FTD), and in patients with FTD. Methods We analysed the UBQLN2 gene in 819 SALS cases, 226 FALS cases, 53 ALS–FTD patients, and 63 patients with a clinical record of FTD. Molecular analysis of the entire coding sequence was carried out in all FALS and ALS–FTD patients, while SALS and FTD patients were analysed specifically for the genomic region coding for the PXX repeat tract. Healthy controls were 845 anonymous blood donors and were screened for the PXX repeat region only. Results We found five different variants in the UBQLN2 gene in five unrelated ALS patients. Three variants, including two novel ones, involved a proline residue in the PXX repeat region and were found in three FALS cases. The other two were novel variants, identified in one FALS and one SALS patient. None of these variants was present in controls, while one control carried a new heterozygous variant. Conclusions Our data support the role of the UBQLN2 gene in the pathogenesis of FALS, being conversely a rare genetic cause in SALS even when complicated by FTD.

[1]  S. Corti,et al.  C9ORF72 repeat expansion in a large Italian ALS cohort: evidence of a founder effect , 2012, Neurobiology of Aging.

[2]  G. Rouleau,et al.  UBQLN2/ubiquilin 2 mutation and pathology in familial amyotrophic lateral sclerosis , 2012, Neurobiology of Aging.

[3]  N. Atsuta,et al.  Analysis of C9orf72 repeat expansion in 563 Japanese patients with amyotrophic lateral sclerosis , 2012, Neurobiology of Aging.

[4]  V. Meininger,et al.  UBQLN2 mutations are rare in French and French–Canadian amyotrophic lateral sclerosis , 2012, Neurobiology of Aging.

[5]  Leonard H van den Berg,et al.  Evidence for an oligogenic basis of amyotrophic lateral sclerosis. , 2012, Human molecular genetics.

[6]  M. Neumann,et al.  Body mass index is associated with biological CSF markers of core brain pathology in Alzheimer's disease , 2012, Neurobiology of Aging.

[7]  P. Tacconi,et al.  ALS/FTD phenotype in two Sardinian families carrying both C9ORF72 and TARDBP mutations , 2012, Journal of Neurology, Neurosurgery & Psychiatry.

[8]  V. Meininger,et al.  Mutations in UBQLN2 are rare in French amyotrophic lateral sclerosis , 2012, Neurobiology of Aging.

[9]  John L. Robinson,et al.  Pattern of ubiquilin pathology in ALS and FTLD indicates presence of C9ORF72 hexanucleotide expansion , 2012, Acta Neuropathologica.

[10]  G. Comi,et al.  Mutational analysis of VCP gene in familial amyotrophic lateral sclerosis , 2012, Neurobiology of Aging.

[11]  Bruce L. Miller,et al.  Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS , 2011, Neuron.

[12]  David Heckerman,et al.  A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD , 2011, Neuron.

[13]  T. Siddique,et al.  Making Connections: Pathology and Genetics Link Amyotrophic Lateral Sclerosis with Frontotemporal Lobe Dementia , 2011, Journal of Molecular Neuroscience.

[14]  J. Haines,et al.  Mutations in UBQLN2 cause dominant X-linked juvenile and adult onset ALS and ALS/dementia , 2011, Nature.

[15]  G. Comi,et al.  Novel optineurin mutations in patients with familial and sporadic amyotrophic lateral sclerosis , 2011, Journal of Neurology, Neurosurgery & Psychiatry.

[16]  O. Hardiman,et al.  Proposed criteria for familial amyotrophic lateral sclerosis , 2011, Amyotrophic Lateral Sclerosis.

[17]  Patrizia Sola,et al.  Exome Sequencing Reveals VCP Mutations as a Cause of Familial ALS , 2011, Neuron.

[18]  Takeo Kato,et al.  Mutations of optineurin in amyotrophic lateral sclerosis , 2010, Nature.

[19]  D. Cleveland,et al.  TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration. , 2010, Human molecular genetics.

[20]  G. Rouleau,et al.  Genetics of motor neuron disorders: new insights into pathogenic mechanisms , 2009, Nature Reviews Genetics.

[21]  G. Comi,et al.  Mutations of FUS gene in sporadic amyotrophic lateral sclerosis , 2009, Journal of Medical Genetics.

[22]  J. Landers,et al.  Analysis of FUS gene mutation in familial amyotrophic lateral sclerosis within an Italian cohort , 2009, Neurology.

[23]  Andrew Menzies,et al.  A systematic, large-scale resequencing screen of X-chromosome coding exons in mental retardation , 2009, Nature Genetics.

[24]  B. Castellotti,et al.  High frequency of TARDBP gene mutations in Italian patients with amyotrophic lateral sclerosis , 2009, Human mutation.

[25]  J L Haines,et al.  Supporting Online Material Materials and Methods Figs. S1 to S7 Tables S1 to S4 References Mutations in the Fus/tls Gene on Chromosome 16 Cause Familial Amyotrophic Lateral Sclerosis , 2022 .

[26]  M. Freedman,et al.  Consensus criteria for the diagnosis of frontotemporal cognitive and behavioural syndromes in amyotrophic lateral sclerosis , 2009, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

[27]  Xun Hu,et al.  TDP-43 Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis , 2008, Science.

[28]  A. Chiò,et al.  Prevalence of SOD1 mutations in the Italian ALS population , 2008, Neurology.

[29]  B. Castellotti,et al.  Identification of new ANG gene mutations in a large cohort of Italian patients with amyotrophic lateral sclerosis , 2008, Neurogenetics.

[30]  D. Thurman,et al.  How common are the “common” neurologic disorders? , 2007, Neurology.

[31]  M. Zeviani,et al.  Superoxide dismutase gene mutations in Italian patients with familial and sporadic amyotrophic lateral sclerosis: identification of three novel missense mutations , 2001, Neuromuscular Disorders.

[32]  P. Howley,et al.  The hPLIC proteins may provide a link between the ubiquitination machinery and the proteasome. , 2000, Molecular cell.

[33]  T. Shows,et al.  Assignment1 of Ubiquilin2 (UBQLN2) to human chromosome Xp11.23→p11.1 by GeneBridge radiation hybrids , 2000, Cytogenetic and Genome Research.

[34]  E. Koonin,et al.  A family of ubiquitin‐like proteins binds the ATPase domain of Hsp70‐like Stch , 2000, FEBS letters.

[35]  M. Swash,et al.  Consensus guidelines for the design and implementation of clinical trials in ALS , 1999, Journal of the Neurological Sciences.

[36]  J. Haines,et al.  Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis , 1993, Nature.

[37]  A. Ludolph,et al.  Amyotrophic lateral sclerosis. , 2012, Current opinion in neurology.

[38]  Emmanouil Collab.  A map of human genome variation from population-scale sequencing , 2011, Nature.